These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29466917)

  • 21. Effectiveness and security of chronic hepatitis C treatment in coinfected patients in real-world.
    Uriarte-Pinto M; Navarro-Aznarez H; De La Llama-Celis N; Arazo-Garcés P; Martínez-Sapiña AM; Abad-Sazatornil MR
    Int J Clin Pharm; 2018 Jun; 40(3):608-616. PubMed ID: 29556931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C Virus Cure in Human Immunodeficiency Virus Coinfection Dampens Inflammation and Improves Cognition Through Multiple Mechanisms.
    Sun B; Abadjian L; Monto A; Freasier H; Pulliam L
    J Infect Dis; 2020 Jul; 222(3):396-406. PubMed ID: 32157304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of hepatitis C: a systematic review.
    Kohli A; Shaffer A; Sherman A; Kottilil S
    JAMA; 2014 Aug; 312(6):631-40. PubMed ID: 25117132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of direct antiviral agents in a cohort of cirrhotic HCV/HIV-coinfected patients.
    Navarro J; Laguno M; Vilchez HH; Guardiola JM; Carrion JA; Force L; Cairó M; Cifuentes C; Vilaró J; Cucurull J; Marco A; Roget M; Erice E; Crespo M;
    J Antimicrob Chemother; 2017 Oct; 72(10):2850-2856. PubMed ID: 29091196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Similar effectiveness of direct-acting antiviral against hepatitis C virus in patients with and without HIV infection.
    Montes ML; Olveira A; Ahumada A; Aldámiz T; García-Samaniego J; Clemente A; Berenguer J; González-García J; Martín-Carbonero L;
    AIDS; 2017 Jun; 31(9):1253-1260. PubMed ID: 28358742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis C virus-human immunodeficiency virus coinfection.
    Sulkowski MS
    Liver Int; 2012 Feb; 32 Suppl 1():129-34. PubMed ID: 22212583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral Combination Therapies for Hepatitis C Virus Infection: Successes, Challenges, and Unmet Needs.
    Naggie S; Muir AJ
    Annu Rev Med; 2017 Jan; 68():345-358. PubMed ID: 27686017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinical management of HCV in the HIV-infected patient.
    Norton B; Naggie S
    Antivir Ther; 2015; 20(5):457-67. PubMed ID: 25346056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mental disorders in HIV/HCV coinfected patients under antiviral treatment for hepatitis C.
    Martin-Subero M; Diez-Quevedo C
    Psychiatry Res; 2016 Dec; 246():173-181. PubMed ID: 27718466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ESRD patients coinfected with human immunodeficiency virus and Hepatitis C: Outcomes and management challenges.
    Sawinski D
    Semin Dial; 2019 Mar; 32(2):159-168. PubMed ID: 30475425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Triple therapy with boceprevir or telaprevir in a European cohort of cirrhotic HIV/HCV genotype 1-coinfected patients.
    Miailhes P; Gilbert C; Lacombe K; Arends JE; Puoti M; Rockstroh JK; Sogni P; Fontaine H; Rosenthal E; Winnock M; Loko MA; Wittkop L; Dabis F; Salmon D;
    Liver Int; 2015 Sep; 35(9):2090-9. PubMed ID: 25650873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of Chronic Hepatitis C in Special Populations.
    Bunchorntavakul C; Tanwandee T
    Gastroenterol Clin North Am; 2015 Dec; 44(4):883-900. PubMed ID: 26600226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Real-World Clinical Efficacy and Tolerability of Direct-Acting Antivirals in Hepatitis C Monoinfection Compared to Hepatitis C/Human Immunodeficiency Virus Coinfection in a Community Care Setting.
    Gayam V; Hossain MR; Khalid M; Chakaraborty S; Mukhtar O; Dahal S; Mandal AK; Gill A; Garlapati P; Ramakrishnaiah S; Mowyad K; Sherigar J; Mansour M; Mohanty S
    Gut Liver; 2018 Nov; 12(6):694-703. PubMed ID: 29938459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liver Fibrosis Progression and Mortality in Hepatitis B- and C-Coinfected Persons Treated With Directly Acting Antiviral Agents: Results From ERCHIVES.
    Butt AA; Yan P; Aslam S; Abou-Samra AB; Sherman KE; Shaikh OS
    Clin Infect Dis; 2020 Jul; 71(3):664-666. PubMed ID: 31840746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High rates of hepatitis C virus (HCV) cure using direct-acting antivirals in HIV/HCV-coinfected patients: a real-world perspective.
    Hawkins C; Grant J; Ammerman LR; Palella F; Mclaughlin M; Green R; Mcgregor D; Stosor V
    J Antimicrob Chemother; 2016 Sep; 71(9):2642-5. PubMed ID: 27330060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiretroviral therapy does not affect response to chronic hepatitis C therapy in HIV-coinfected patients.
    De Leon LB; Tovo CV; Kliemann DA; De Mattos AA; Feltrin AA; Pacheco LS; De Almeida PR
    J Infect Dev Ctries; 2016 Aug; 10(7):762-9. PubMed ID: 27482809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Challenges in Special Populations: HIV/HCV Coinfection, Liver Transplantation and Patients with End-Stage Renal Disease.
    Bonacci M; Lens S; Mariño Z; Forns X
    Dig Dis; 2016; 34(4):317-26. PubMed ID: 27170384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of HIV infection on sustained virological response to treatment against hepatitis C virus with pegylated interferon plus ribavirin.
    Monje-Agudo P; Castro-Iglesias A; Rivero-Juárez A; Martínez-Marcos F; Ortega-González E; Real LM; Pernas B; Merchante N; Cid P; Macías J; Merino MD; Rivero A; Mena A; Neukam K; Pineda JA;
    Eur J Clin Microbiol Infect Dis; 2015 Oct; 34(10):1929-36. PubMed ID: 26155784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Telaprevir for HIV/hepatitis C virus-coinfected patients failing treatment with pegylated interferon/ribavirin (ANRS HC26 TelapreVIH): an open-label, single-arm, phase 2 trial.
    Cotte L; Braun J; Lascoux-Combe C; Vincent C; Valantin MA; Sogni P; Lacombe K; Neau D; Aumaitre H; Batisse D; de Truchis P; Gervais A; Michelet C; Morlat P; Vittecoq D; Rosa I; Bertucci I; Chevaliez S; Aboulker JP; Molina JM;
    Clin Infect Dis; 2014 Dec; 59(12):1768-76. PubMed ID: 25139963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treating Hepatitis C in a Ryan White-Funded HIV Clinic: Has the Treatment Uptake Improved in the Interferon-Free Directly Active Antiviral Era?
    Cope R; Glowa T; Faulds S; McMahon D; Prasad R
    AIDS Patient Care STDS; 2016 Feb; 30(2):51-5. PubMed ID: 26744994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.